Contributions of amino acid, acylcarnitine and sphingolipid profiles to type 2 diabetes risk among South-Asian Surinamese and Dutch adults

Muilwijk, M., Goorden, S. M.I., Celis-Morales, C. , Hof, M. H., Ghauharali-van der Vlugt, K., Beers-Stet, F. S., Gill, J. M.R., Vaz, F. M. and van Valkengoed, I. G.M. (2020) Contributions of amino acid, acylcarnitine and sphingolipid profiles to type 2 diabetes risk among South-Asian Surinamese and Dutch adults. BMJ Open Diabetes Research and Care, 8(1), e001003. (doi: 10.1136/bmjdrc-2019-001003) (PMID:32376636) (PMCID:PMC7228466)

[img]
Preview
Text
215591.pdf - Published Version
Available under License Creative Commons Attribution.

2MB

Abstract

Introduction: People of South Asian origin are at high risk of type 2 diabetes (T2D), but the underpinning mechanisms are not fully understood. We determined ethnic differences in acylcarnitine, amino acid and sphingolipid concentrations and determined the associations with T2D. Research design and methods: Associations between these metabolites and incident T2D among Dutch and South-Asian Surinamese were determined in participants from the Healthy Life in an Urban Setting (HELIUS) study (Amsterdam, the Netherlands) using Prentice-weighted Cox regression. The HELIUS study includes 95 incident T2D cases and a representative subcohort of 700 people from a cohort of 5977 participants with a mean follow-up of 4 years. Results: Concentrations of acylcarnitines were comparable between both ethnic groups. Amino acid and lactosylceramide concentrations were higher among South-Asian Surinamese than Dutch (eg, isoleucine 65.7 (SD 16.3) vs 60.7 (SD 15.6) µmol/L). Ceramide concentrations were lower among South-Asian Surinamese than Dutch (eg, Cer d18:1 8.48 (SD 2.04) vs 9.08 (SD 2.29) µmol/L). Metabolic dysregulation preceded T2D without evidence for a multiplicative interaction by ethnicity. Most amino acids and (dihydro)ceramides were associated with increased risk (eg, Cer d18:1 HR 2.38, 95% CI 1.81 to 3.12) while acylcarnitines, glycine, glutamine and lactosylceramides were associated with decreased risk for T2D (eg, LacCer d18:2 HR 0.56, 95% CI 0.42 to 0.77). Conclusions: Overall, these data suggest that the disturbances underlying amino acid and sphingolipid metabolism may be predictive of T2D risk in populations of both South Asian and European background. These observations may be used as starting point to unravel the underlying metabolic disturbances.

Item Type:Articles
Additional Information:This work was supported by the European Union Health Programme 2014–2020 (grant number 664609 HP-PJ- 2014). The HELIUS study is conducted by the Academic Medical Center Amsterdam and the Public Health Service of Amsterdam. Both organizations provided core support for HELIUS. The HELIUS study is also funded by the Dutch Heart Foundation, the Netherlands Organization for Health Research and Development (ZonMw), the European Union (FP-7), and the European Fund for the Integration of non-EU immigrants (EIF).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Celis, Dr Carlos
Authors: Muilwijk, M., Goorden, S. M.I., Celis-Morales, C., Hof, M. H., Ghauharali-van der Vlugt, K., Beers-Stet, F. S., Gill, J. M.R., Vaz, F. M., and van Valkengoed, I. G.M.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:BMJ Open Diabetes Research and Care
Publisher:BMJ Publishing Group
ISSN:2052-4897
ISSN (Online):2052-4897
Published Online:05 May 2020
Copyright Holders:Copyright © 2020 The Authors
First Published:First published in BMJ Open Diabetes Research and Care 8(1):e001003
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record